Compare Kinder Morgan Inc (KMI) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Kinder Morgan Inc trades at $33.59 (market cap $74.26B), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: Kinder Morgan Inc is far larger — about 8.4× Kymera Therapeutics Inc. Common Stock's market cap, and Kinder Morgan Inc pays a 3.54% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kinder Morgan Inc for 151 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| KMI | KYMR | |
|---|---|---|
Market Cap | $74.26B | $8.88B |
Volume | 12,072,157 | 1,028,790 |
Sector | Energy | Health |
52-Week High | $34.31 | $127.31 |
52-Week Low | $25.84 | $55.80 |
Typical Hold Time | 151 Days | 0 Days |
Enterprise Value | $106.31B | $8.27B |
Dividend Yield | 3.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $33.43, up 1.06% with a bullish technical signal and consistent earnings beats. The company demonstrates strong fundamentals with 2025 revenue of $16.94B, net income margin of 19.31%, and robust cash flow generation. Recent news highlights KMI's $6-7B growth pipeline and resilient midstream model amid energy market volatility.
KMI presents a compelling investment case with analyst consensus target of $37.20 (11% upside), strong dividend yield, and exposure to growing natural gas demand. Key risks include energy price volatility, high debt levels ($29.66B long-term), and interest rate sensitivity. The stock offers income and growth potential but requires monitoring of leverage and energy market conditions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
